Table 1.
Rate of primary systemic therapy | Prior COVID-19 | During COVID-19 | P value |
---|---|---|---|
<10% | 39 (10.3%) | 88 (23.3%) | 0.0001 |
10–20% | 159 (42.2%) | 143 (37.9%) | 0.2645 |
21–30% | 127 (33.7%) | 100 (26.5%) | 0.0383 |
>30% | 52 (13.8%) | 46 (12.2%) | 0.5883 |
Rate of primary systemic therapy | Prior COVID-19 | During COVID-19 | P value |
---|---|---|---|
<10% | 39 (10.3%) | 88 (23.3%) | 0.0001 |
10–20% | 159 (42.2%) | 143 (37.9%) | 0.2645 |
21–30% | 127 (33.7%) | 100 (26.5%) | 0.0383 |
>30% | 52 (13.8%) | 46 (12.2%) | 0.5883 |